MENU
BMEA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Biomea Fusion (BMEA) Ownership - Who owns Biomea Fusion?
Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases... Show more
Profile
Industry
N/A
Address
900 Middlefield Road
Phone
+1 650 980-9099
Employees
103
Web
https://www.biomeafusion.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
54.48M
P/E Ratio
N/A
Total Cash
35.86M
Projected Growth
N/A
Total Debt
7.93M
Revenue
N/A
Risk (Beta)
-0.32
Dividend Yield
N/A
Total Cash/Share
0.95
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BMEA
Capitalization
54.5M
P/E Ratio
N/A
Risk (Beta)
-0.32
Dividend Yield
N/A
Total Cash
35.9M
Total Cash/Share
0.95
Total Debt
7.93M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
28.7M
P/B Ratio
1.90
Cash Flow
N/A
Earnings
-3.54
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
2.25
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-130.93M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-115.08
Shares Held By Institutions
141M
Shares Outstanding - Current
37.6M
Total Liabilities
26.3M
Total Volume MTD
N/A
Value
1
Gain YTD
-62.629
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
900 Middlefield Road
Phone
+1 650 980-9099
Employees
103
Web
https://www.biomeafusion.com